- B.S., Chemistry, Korea University (Seoul, Korea)
- Ph.D., Polymer Sci. & Eng., University of Massachusetts, Amherst
Dr. Yu is developing innovative diagnostic/therapeutic molecules, biomaterials, and piezoelectric materials. In particular, the collagen hybridizing peptide he developed and commercialized (3helix, Inc) is considered a breakthrough technology in detecting and studying collagen remodeling, with world-wide use in over a hundred different research labs. The technology is being developed into histology reagents, in vivo imaging probes, therapeutics, and cosmetics ingredients.